National health impacts from PM2.5 exposure in Bangladesh
This chart highlights the national health impacts of PM2.5 exposure, showing estimated cases for various conditions such as asthma, chronic obstructive pulmonary disease (COPD), ischemic heart disease, and others.
Filter by specific health outcomes to visualise the nationwide burden of air pollution-related illnesses and their significance and compare the health impacts under 4 different air quality scenarios: current levels, air quality under Bangladesh national guidelines, WHO Guidelines, 2005 and WHO Guidelines, 2021.
Division-level health impacts from PM2.5 exposure
This chart presents health impacts across Bangladesh’s eight divisions and illustrates how conditions such as lower respiratory infections and stroke vary geographically, with urban areas like Dhaka and Chattogram facing higher burdens due to industrial and vehicular emissions.
Filter health outcomes to explore how air pollution affects different regions and identify priority areas for intervention.
Aggregated district-level health impacts from PM2.5 exposure
This chart provides a more granular view of health impacts, breaking down data to the district level. This data level helps highlight disparities within divisions, guiding targeted mitigation strategies in both urban hotspots and rural areas with elevated risks.
Filter by specific districts to identify localised health burdens related to PM2.5 pollution.
District-level causes of health impacts from PM2.5 exposure
This chart further examines the health impacts at the district level by allowing users to isolate individual causes contributing to each health outcome. By offering this level of granularity, the chart provides valuable insights into the drivers of aggregated health impacts, helping to identify priority areas for targeted interventions. This tool is particularly useful for understanding the distribution and severity of specific health risks, guiding more nuanced policy and public health responses.
Filter by specific contributors to Years of Life Lost (YLL), such as chronic obstructive pulmonary disease, ischemic heart disease, lower respiratory infections, lung cancer, or stroke.